LD-2 disclosure · 1st Quarter - Report
ELI LILLY & COMPANY
Client
- Description
- Pharmaceutical/ Health Products
- Location
- District of Columbia · United States of America
Registrant
- Description
- Lobbying Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
6 issuesTaxation/Internal Revenue Code
International and domestic tax issues.
LobbyistsSUSAN HIRSCHMANN · mr CHRISTOPHER W HATCHER · mr MATTHEW B HOEKSTRA · JEANNE HAGGERTY
Covered position (JEANNE HAGGERTY): Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
General education about policies impacting pharmaceutical development, approval and reimbursement. Policies impacting pharmaceutical research, development, and approval. Policies impacting public health preparedness and prevention and U.S. address to the Covid-19 pandemic, 340B Program. "Inflation Reduction Act of 2022" (PL 117-169). Accelerated Approval pathway; Alzheimers diagnostics policies. Pharmacy benefit manager reform proposals. Treat and Reduce Obesity Act of 2023.
LobbyistsSUSAN HIRSCHMANN · ms MELINDA M MAXFIELD · mr MATTHEW B HOEKSTRA · CHRISTOPHER E. WILCOX · JEANNE HAGGERTY
Covered position (CHRISTOPHER E. WILCOX): LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings
Covered position (JEANNE HAGGERTY): Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member